Repository logo
 
Publication

Study of Mechanisms for Acetyl-L-Carnitine Neuroprotective Action

dc.contributor.authorCunha, Lídia
dc.contributor.authorDamiani, Danira
dc.contributor.authorAlves, Cecília J.
dc.contributor.authorMetello, Luís F.
dc.contributor.authorSummavielle, Teresa
dc.date.accessioned2015-05-27T13:58:31Z
dc.date.available2015-05-27T13:58:31Z
dc.date.issued2010-10-09
dc.description.abstractIntroduction: Acetyl-L-Carnitine (ALC) has been proposed to have beneficial effects in chronic neurodegenerative disorders caused by production of abnormal proteins, mitochondrial dysfunction and oxidative stress. Recently, our group demonstrated that pre-treatment with ALC confers effective neuroprotection against 3,4- methylenedioximethamphetamine (MDMA)-induced neurotoxicity. These pre-clinical studies reinforce the beneficial potential of ALC as a neuroprotectant in neurodegenerative disorders. However, little is known about the molecular mechanisms underlying ALC action.en
dc.identifier.urihttp://hdl.handle.net/10400.22/6125
dc.language.isoengpor
dc.titleStudy of Mechanisms for Acetyl-L-Carnitine Neuroprotective Actionpor
dc.typelecture
dspace.entity.typePublication
oaire.citation.conferencePlaceInternationalpor
oaire.citation.titleVienna 2010 - Annual Congress of the European Association of Nuclear Medicinepor
person.familyNameCunha
person.familyNameSummavielle
person.givenNameLídia
person.givenNameTeresa
person.identifier677706
person.identifier.ciencia-idC41E-0816-5C85
person.identifier.orcid0000-0002-9260-8093
person.identifier.orcid0000-0003-2548-6281
person.identifier.ridC-9776-2012
person.identifier.scopus-author-id6603092949
rcaap.rightsopenAccesspor
rcaap.typelecturepor
relation.isAuthorOfPublicationed51e8c5-a1c2-40e6-b976-57af77446e1b
relation.isAuthorOfPublication207ee2de-85a0-4144-9e7e-b376c600e065
relation.isAuthorOfPublication.latestForDiscoveryed51e8c5-a1c2-40e6-b976-57af77446e1b

Files

Original bundle
Now showing 1 - 1 of 1
No Thumbnail Available
Name:
Study of Mechanisms for Acetyl-L-Carnitine Neuroprotective Action.pdf
Size:
219.22 KB
Format:
Adobe Portable Document Format
License bundle
Now showing 1 - 1 of 1
No Thumbnail Available
Name:
license.txt
Size:
1.71 KB
Format:
Item-specific license agreed upon to submission
Description: